Tech Company Financing Transactions
Atrin Pharmaceuticals Funding Round
On 4/8/2016, Atrin Pharmaceuticals received $1.5 million in funding from private investors.
Transaction Overview
Company Name
Announced On
4/8/2016
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$1,500,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 9 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3805 Old Easton Rd.
Doylestown, PA 18902
USA
Doylestown, PA 18902
USA
Phone
Website
Email Address
Overview
Atrin Pharmaceuticals is a dynamic biopharmaceutical firm focused on the discovery and development of proprietary medications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Oren Gilad
Chief Medical Officer
Rifat Pamucku
Chief Technical Officer
Dansu Li
VP - Bus. Development
Michael King
Browse more venture capital transactions:
Prev: 4/8/2016: MobileLogix venture capital transaction
Next: 4/8/2016: Globality venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on all VC transactions involving tech companies. VC transactions reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs